Welcome to the Drug Delivery Lab!
Administration of free drug to treat diseases, in many cases, is associated with critical drawbacks like off-target effects and low in vivo stability. This hinders the treatment of the disease. With our versatile expertise, we aim to reduce these shortcomings. Our lab focuses on using wide range of tools and concepts such as nano- and micro-particles, hydrogels, scaffolds and 3D organoids to generate treatment for diseases like Tuberculosis and Osteoarthritis. With our translational outlook, we plan to create clinically viable therapeutic options to treat such diseases.

Latest News

    • 23rd November 2021
      Pallavi is selected as eLife Community Ambassador!
    • 24th September 2021
      Ameya's manuscript on liposomal-RvD1 delivery has been accepted at Bioengineering and Translational Medicine. Congratulations!
    • 16th September 2021
      Rajesh is selected as the top innovators in BRICS_YSF 2021 conclave!
    • 31st August 2021
      Rachit is selected as an Early Career Editorial Board Member for the journal JBMR-A. Congratulations!
    • 31st August 2021
      Anil has been appointed as a senior scientist in RapidDx Technologies Pvt. Ltd. Congratulations!

Latest Publications

  • Dravid A.A.; Dhanabalan K.M.; Agarwal S.; Agarwal R., Resolvin D1-loaded nanoliposomes promote M2 macrophage polarization and are effective in treatment of Osteoarthritis. Bioengineering and Translational Medicine. (2021) In press
  • Dhanabalan K.M.; Dravid A.A.; Agarwal S.; Sharath R.K.; Padmanabhan A.K., Agarwal R., Rapamycin microparticles induce autophagy, prevent senescence and are effective in treatment of Osteoarthritis. BioRxiv.
  • Goswami A.; Sharma P.R.; Agarwal R., Combatting intracellular pathogens using bacteriophage delivery. Critical Reviews in Microbiology. (2021) 1-18
  • Kalapala Y.C.; Sharma P.R.; Agarwal R., Antimycobacterial potential of Mycobacteriophage under disease-mimicking conditions. Frontiers in Microbiology. 11 (2020) 583661